SacredBod
0
LL-37 (Antimicrobial Peptide) — SacredBod supplement bottle (illustrative)
Supplement · Peptide & Immune

LL-37 (Antimicrobial Peptide)

Cathelicidin LL-37

As directed · vegan · gluten-free · 60 caps

frequent infections skinmucous membraneimmune system
Find on Amazon →

Affiliate link · we earn from qualifying purchases. No paid placements.

What it is

LL-37 (Antimicrobial Peptide) is a peptide & immune supplement. LL-37 is the active fragment of human cathelicidin, a host-defence peptide central to innate immunity, here as a research compound. Used in adult dosing protocols in India and internationally, it is sold as a single-ingredient supplement.

How it works

It disrupts microbial membranes, neutralises endotoxin and modulates immune-cell recruitment and wound healing as part of the innate antimicrobial response. Effects are dose-dependent and typically measurable within research compound.

Who should take it

Adults exploring innate-immune and antimicrobial research support; clinical evidence is preliminary.

Avoid / careful

Research-grade only; human safety/efficacy unestablished. Vitamin D supports endogenous LL-37 production and is the evidence-based route. Consult a clinician.

When to take it

Morning
Noon
Evening
Night

How to take it

With food
Empty stomach
Before food

Flexible — works in any of the above.

FAQs

Frequently asked

What is LL-37?
LL-37 is the primary human cathelicidin antimicrobial peptide, a key component of the innate immune system.
How does LL-37 work?
It directly targets and disrupts the membranes of bacteria, fungi, and some viruses, and can also modulate immune responses.
Is LL-37 safe for general use?
LL-37 is currently considered a research-grade compound, and its safety and efficacy in humans for supplementation have not been established.

Editorial notes

SacredBod's longer take on LL-37 (Antimicrobial Peptide) — context the structured blocks above don't capture.

About LL-37 (Antimicrobial Peptide)

Cathelicidin-derived host-defence peptide studied for innate antimicrobial activity..

How it works

It disrupts microbial membranes, neutralises endotoxin and modulates immune-cell recruitment and wound healing as part of the innate antimicrobial response. Effects are dose-dependent and typically measurable within research compound.

Who it’s for

Adults exploring innate-immune and antimicrobial research support; clinical evidence is preliminary.

Dosage & timing

  • Typical dose: As directed
  • Best time: morning
  • With food: flexible
  • Expected onset: Research compound.

Safety

Research-grade only; human safety/efficacy unestablished. Vitamin D supports endogenous LL-37 production and is the evidence-based route. Consult a clinician.

Added to your stack.